Resistance to apoptosis can be acquired by cancer cells by e.g. loss of p53 (which normally activates pro-apoptotic proteins and represents the most common loss of a pro-apoptotic regulator), or by activation or upregulation of anti-apoptotic Bcl2. This evidence concerns the gene BCL2 and cancer.